TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find October 25, 2002